Determination of the Diagnostic Detection Rate of Axumin (Fluciclovine) Digital PET/CT, Post-prostatectomy

Stopped Lack of efficacy of Axumin and resultant lack of interest in recruitment. FDA approval of PSMA also hampered enrollment.

Conditions

• Prostatic Neoplasm

Interventions

• DIAGNOSTIC_TEST: Fluciclovine PET/CT using a digital PET/CT

Sponsor

University of Vermont